Please assess the completion status of the following clinical trial:

Trial Title: PET Imaging of Endotoxin-induced iNOS Activation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy man or woman, any race or ethnicity, age 19 - 44 years old~* Screening Pulmonary Function Test~* Screening oxygen saturation by pulse oximetry \>97% on room air~* Capable of lying still and supine within the PET/CT scanner for 1.5 hours~* Capable of following instructions for breathing protocol during CT portion of PET/CT~* Able and willing to give informed consent~* BMI \< 35~Exclusion Criteria:~* Pregnancy (confirmed by qualitative serum hCG pregnancy test)~* Lactation~* Active menstruation~* History of cardiopulmonary disease~* Currently taking any prescription medications~* History of tobacco use or illicit drug use within the past year~* Presence of implanted electronic medical device~* Enrollment in another research study of an investigational drug~* Known allergy to both trimethoprim/sulfamethoxazole and amoxicillin~* Known allergy to drugs routinely used during bronchoscopy~* Inability lie flat for 1.5 hours for PET/CT scans or follow breathing protocol instructions for the CT portion of the PET/CT

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 44 Years
- Healthy Volunteers: t

Study Arms:
- Endotoxin and [18F](+/-)NOS (Type: EXPERIMENTAL): All volunteers in this study will receive endotoxin in a single segment of the lung to induce mild, self-limited inflammation. They will also be imaged before and after endotoxin instillation with the novel PET tracer F-18 (+/-) NOS

Based on this trial design, predict the completion outcome and termination type (if applicable).